vs
COMMERCE BANCSHARES INC（CBSH）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是COMMERCE BANCSHARES INC的1.3倍（$622.0M vs $475.7M），Royalty Pharma plc净利率更高（34.4% vs 29.8%，领先4.7%），COMMERCE BANCSHARES INC同比增速更快（11.1% vs 4.8%），过去两年COMMERCE BANCSHARES INC的营收复合增速更高（7.1% vs 4.6%）
Commerce Bancshares, Inc.是总部位于美国密苏里州的区域性银行控股公司，在堪萨斯城和圣路易斯设有核心办公点，旗下Commerce Bank提供多元化金融服务，覆盖企业及个人银行、财富管理、关联公司投资等业务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CBSH vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.3倍
$475.7M
营收增速更快
CBSH
高出6.4%
4.8%
净利率更高
RPRX
高出4.7%
29.8%
两年增速更快
CBSH
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $475.7M | $622.0M |
| 净利润 | $141.6M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 29.8% | 34.4% |
| 营收同比 | 11.1% | 4.8% |
| 净利润同比 | 10.5% | 2.9% |
| 每股收益（稀释后） | $0.96 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBSHRPRX
| Q1 26 | $475.7M | — | ||
| Q4 25 | $449.4M | $622.0M | ||
| Q3 25 | $441.0M | $609.3M | ||
| Q2 25 | $445.8M | $578.7M | ||
| Q1 25 | $428.1M | $568.2M | ||
| Q4 24 | $422.1M | $593.6M | ||
| Q3 24 | $421.4M | $564.7M | ||
| Q2 24 | $414.5M | $537.3M |
净利润CBSHRPRX
| Q1 26 | $141.6M | — | ||
| Q4 25 | $140.7M | $214.2M | ||
| Q3 25 | $141.5M | $288.2M | ||
| Q2 25 | $152.5M | $30.2M | ||
| Q1 25 | $131.6M | $238.3M | ||
| Q4 24 | $136.1M | $208.2M | ||
| Q3 24 | $138.0M | $544.0M | ||
| Q2 24 | $139.6M | $102.0M |
营业利润率CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 40.8% | 62.4% | ||
| Q3 25 | 41.9% | 70.1% | ||
| Q2 25 | 44.0% | 36.3% | ||
| Q1 25 | 39.2% | 94.0% | ||
| Q4 24 | 41.2% | 60.9% | ||
| Q3 24 | 42.4% | — | ||
| Q2 24 | 43.4% | 50.2% |
净利率CBSHRPRX
| Q1 26 | 29.8% | — | ||
| Q4 25 | 31.3% | 34.4% | ||
| Q3 25 | 32.1% | 47.3% | ||
| Q2 25 | 34.2% | 5.2% | ||
| Q1 25 | 30.7% | 41.9% | ||
| Q4 24 | 32.2% | 35.1% | ||
| Q3 24 | 32.8% | 96.3% | ||
| Q2 24 | 33.7% | 19.0% |
每股收益（稀释后）CBSHRPRX
| Q1 26 | $0.96 | — | ||
| Q4 25 | $0.86 | $0.49 | ||
| Q3 25 | $1.06 | $0.67 | ||
| Q2 25 | $1.14 | $0.07 | ||
| Q1 25 | $0.98 | $0.55 | ||
| Q4 24 | $0.83 | $0.46 | ||
| Q3 24 | $1.01 | $1.21 | ||
| Q2 24 | $1.03 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $4.3B | $9.7B |
| 总资产 | $35.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益CBSHRPRX
| Q1 26 | $4.3B | — | ||
| Q4 25 | $3.8B | $9.7B | ||
| Q3 25 | $3.8B | $9.6B | ||
| Q2 25 | $3.6B | $9.5B | ||
| Q1 25 | $3.5B | $9.8B | ||
| Q4 24 | $3.3B | $10.3B | ||
| Q3 24 | $3.4B | $10.3B | ||
| Q2 24 | $3.1B | $9.8B |
总资产CBSHRPRX
| Q1 26 | $35.7B | — | ||
| Q4 25 | $32.9B | $19.6B | ||
| Q3 25 | $32.3B | $19.3B | ||
| Q2 25 | $32.3B | $18.3B | ||
| Q1 25 | $32.4B | $17.6B | ||
| Q4 24 | $32.0B | $18.2B | ||
| Q3 24 | $31.5B | $18.0B | ||
| Q2 24 | $30.6B | $17.7B |
负债/权益比CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | $645.1M | $827.1M | ||
| Q3 25 | $129.0M | $702.6M | ||
| Q2 25 | $111.2M | $364.0M | ||
| Q1 25 | $138.6M | $596.1M | ||
| Q4 24 | $577.9M | $742.5M | ||
| Q3 24 | $431.7M | $703.6M | ||
| Q2 24 | $147.4M | $658.2M |
自由现金流CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | $592.4M | — | ||
| Q3 25 | $113.3M | — | ||
| Q2 25 | $100.5M | — | ||
| Q1 25 | $126.0M | — | ||
| Q4 24 | $531.7M | — | ||
| Q3 24 | $419.1M | — | ||
| Q2 24 | $138.9M | — |
自由现金流率CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 131.8% | — | ||
| Q3 25 | 25.7% | — | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | 29.4% | — | ||
| Q4 24 | 126.0% | — | ||
| Q3 24 | 99.5% | — | ||
| Q2 24 | 33.5% | — |
资本支出强度CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 11.7% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | 2.1% | — |
现金转化率CBSHRPRX
| Q1 26 | — | — | ||
| Q4 25 | 4.59× | 3.86× | ||
| Q3 25 | 0.91× | 2.44× | ||
| Q2 25 | 0.73× | 12.06× | ||
| Q1 25 | 1.05× | 2.50× | ||
| Q4 24 | 4.25× | 3.57× | ||
| Q3 24 | 3.13× | 1.29× | ||
| Q2 24 | 1.06× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBSH
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
